Paid Clinical Trials in Webster, TX
As of September 2026, 65 paid clinical trials are recruiting in Webster, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Webster offers studies at sites including Texas Oncology - Gulf Coast for conditions such as Ulcerative Colitis, Carcinoma, Non-Small-Cell Lung, Crohn's Disease, Neoplasm Metastasis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Webster
Trials by drug in Webster
Filter results
Newly added in Webster
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Photodynamic Therapy For Onychomycosis
64 clinical trials
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Top Research Study Locations in Webster
Researchers run research studies in Webster, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Texas Oncology - Gulf Coast | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 9 |
| Tranquil Clinical Research | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 5 |
| Center for Clinical Studies | Atopic Dermatitis, Moderate to Severe Glabellar Lines, Overweight or Obesity | 4 |
| GI Alliance - Webster | Crohn's Disease, Ulcerative Colitis | 3 |
| Tranquil Research | Colorectal Cancer, Myelodysplastic Syndromes, Sjogren Disease | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Center for Clinical Studies, LTD. LLP | Herpes Zoster (HZ), Nodular Basal Cell Carcinoma, Superficial Basal Cell Carcinoma | 2 |
| GI Alliance-Webster | Constipation, Irritable Bowel Syndrome, Ulcerative Colitis | 2 |
| Oruka Therapeutics Investigative Site | Plaque Psoriasis | 2 |
| Shady Grove Houston | In Vitro Maturation of Oocytes, Infertility (IVF Patients) | 2 |
| TDDC GI Alliance research Webster | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Center for Clinical Studies - Clear Lake | Alopecia Areata | 1 |
| Center for Clinical Studies at Webster Clear Lake | Cutaneous Squamous Cell Carcinoma (CSCC) | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Cullinan Investigative Site | Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA) | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| Grifols Investigative site | Hepatitis B Virus Infection | 1 |
| Houston Physicians Hospital | Lumbar Spinal Stenosis | 1 |
| Houston Skin | Onychomycosis of Toenail | 1 |
| Investigative | Hidradenitis Suppurativa (HS) | 1 |
| Mirador Therapeutics Selected Site | Crohn's Disease, Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) | 1 |
| Renovatio Clinical | Idiopathic Pulmonary Fibrosis (IPF) | 1 |
| Texas Oncology - Deke Slayton Cancer Center | Metastatic Colorectal Cancer | 1 |
| Texas Oncology - Gulf Coast (SCRI) | Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer | 1 |
Active & Upcoming Studies in Webster (2026)
Recruiting trials in Webster grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (24 active studies)
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
Diabetes & metabolic (4 active studies)
- First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671 · Phase 1, Phase 2 · Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) · Phase 4 · Eli Lilly and Company
HIV / STI (1 active study)
Cardiovascular (1 active study)
Common conditions studied in Webster
- Ulcerative Colitis (4 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
- Crohn's Disease (3 active studies)
- Neoplasm Metastasis (3 active studies)
- Plaque Psoriasis (3 active studies)
- Breast Cancer (2 active studies)
Leading research sponsors in Webster
- Eli Lilly and Company
- Pfizer
- Takeda
- Cullinan Therapeutics Inc.
- Hoffmann-La Roche
Frequently asked questions
How many paid clinical trials are currently recruiting in Webster?
There are approximately 65 recruiting clinical trials in Webster, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Webster pay participants?
Most recruiting trials in Webster compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Webster?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Webster?
The most common conditions under active study in Webster include Ulcerative Colitis (4), Carcinoma, Non-Small-Cell Lung (3), Crohn's Disease (3), Neoplasm Metastasis (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Webster?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Webster on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Webster?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Webster?
Recruiting research sites in Webster include Texas Oncology - Gulf Coast, Tranquil Clinical Research, Center for Clinical Studies, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Webster right now?
The largest active categories in Webster are Cancer & tumors (24), Diabetes & metabolic (4), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.